Millennium Management LLC cut its stake in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 45.1% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 336,679 shares of the health services provider's stock after selling 276,420 shares during the period. Millennium Management LLC owned about 0.59% of Maximus worth $25,133,000 at the end of the most recent quarter.
A number of other large investors also recently added to or reduced their stakes in MMS. UMB Bank n.a. increased its stake in Maximus by 79.8% in the 4th quarter. UMB Bank n.a. now owns 356 shares of the health services provider's stock valued at $27,000 after buying an additional 158 shares during the period. V Square Quantitative Management LLC raised its holdings in Maximus by 65.9% in the fourth quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider's stock valued at $34,000 after buying an additional 180 shares during the period. R Squared Ltd purchased a new position in Maximus in the fourth quarter valued at approximately $54,000. IFP Advisors Inc raised its stake in shares of Maximus by 62.4% during the fourth quarter. IFP Advisors Inc now owns 786 shares of the health services provider's stock valued at $59,000 after purchasing an additional 302 shares during the period. Finally, Farther Finance Advisors LLC increased its stake in shares of Maximus by 109.2% in the fourth quarter. Farther Finance Advisors LLC now owns 820 shares of the health services provider's stock worth $61,000 after buying an additional 428 shares during the last quarter. 97.21% of the stock is currently owned by institutional investors and hedge funds.
Insider Transactions at Maximus
In related news, Director Jan Madsen sold 2,439 shares of the stock in a transaction dated Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total transaction of $165,144.69. Following the completion of the sale, the director now owns 18,097 shares in the company, valued at approximately $1,225,347.87. This trade represents a 11.88% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 1.60% of the company's stock.
Maximus Price Performance
Shares of MMS traded down $1.33 during trading hours on Friday, hitting $72.36. The stock had a trading volume of 456,402 shares, compared to its average volume of 562,495. The company's fifty day moving average is $69.37 and its two-hundred day moving average is $72.05. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.72 and a quick ratio of 1.72. Maximus, Inc. has a 52 week low of $63.77 and a 52 week high of $93.97. The stock has a market capitalization of $4.08 billion, a price-to-earnings ratio of 15.56 and a beta of 0.61.
Maximus (NYSE:MMS - Get Free Report) last released its quarterly earnings data on Thursday, May 8th. The health services provider reported $2.01 earnings per share for the quarter, topping the consensus estimate of $1.37 by $0.64. The business had revenue of $1.36 billion for the quarter, compared to analyst estimates of $1.29 billion. Maximus had a net margin of 5.28% and a return on equity of 21.95%. Maximus's quarterly revenue was up 1.0% compared to the same quarter last year. During the same quarter last year, the firm earned $1.57 EPS. On average, analysts anticipate that Maximus, Inc. will post 6.15 EPS for the current year.
Maximus Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Saturday, May 31st. Investors of record on Thursday, May 15th will be issued a $0.30 dividend. The ex-dividend date is Thursday, May 15th. This represents a $1.20 dividend on an annualized basis and a yield of 1.66%. Maximus's dividend payout ratio (DPR) is presently 23.86%.
Analyst Ratings Changes
Separately, Wall Street Zen downgraded shares of Maximus from a "buy" rating to a "hold" rating in a research report on Thursday, May 15th.
View Our Latest Analysis on MMS
About Maximus
(
Free Report)
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Read More

Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.